地榆升白片治疗艾滋病并发白细胞减少症的临床疗效评价

The clinical study on burnet root tablets for the treatment of acquired immunodeficiency syndrome with leucocytopenia

目的:探讨地榆升白片治疗艾滋病(AIDS)所致白细胞减少症的临床疗效。方法:选取AIDS所致白细胞减少症患者84例,分为治疗组和对照组。治疗组48例,行高效抗逆转录病毒(HAART)联合地榆升白片治疗;对照组36例,行HAART联合鲨肝醇、维生素B4治疗。分析两组治疗的有效率以及外周血白细胞水平。结果:治疗组总有效率(87.5%)高于对照组(66.7%),两组比较差异有统计学意义(P<0.05);治疗组在治疗后第4周、第8周的外周血白细胞数均显著高于对照组(P<0.05)。结论:地榆升白片治疗AIDS并发白细胞减少症安全、有效。

Objective：To evaluate the efficacy of burnet root tablets on the treatment of acquired immunodeficiency syn-drome（ AIDs）with leucocytopenia. Methods：Eighty—four cases of AIDs patients were randomly divided into two groups. 48 patients in experimental group were treated with highly active anti—retroviral therapy（ HAART）plus burnet root tablets. 36 patients in control group were treated with HAART plus batilol and vitamin B4. The data of effective rate and peripheral blood leukocyte were analyzed retrospectively. Results：The effective rate of the experimental group（87. 5%）is significantly higher than in the control group（66. 7%）. The level of peripheral blood leukocyte in the experimental group is significantly higher than that in the control group after 4 weeks,8 weeks. Conclusion：The treatment of diyushengbai tablets for AIDs with leukope-nia is safe and effective.